The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...
Read More

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

by | February 12, 2018 | In the News | 0 Comments

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders...
Read More

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

by | February 12, 2018 | Press Releases | 0 Comments

Results Published in the Journal of Addiction Research and Therapy Shows Nearly 97% Accuracy in Identifying Patients At-Risk of Prescription Opioid Abuse IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces a new study validating the...
Read More

April 25, 2017 – Proove Release: Milestone of the World’s Largest Biobank and Big Data Set in Chronic Pain –

by | February 12, 2018 | Press Releases | 0 Comments

Proove® Announces Huge Milestone for its Proove Nexus™ Big Data Platform Commemorating National DNA Day IRVINE, Calif., April 25, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its Proove Nexus™ platform is the World's Largest DNA Pain Biobank and Big...
Read More

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...
Read More

October 23, 2015 – Proove Release: Proove Partners with USC to Conduct Research

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences, a commercial and research leader in personalized medicine, is excited to announce their partnership with the Keck Medicine of the University of Southern California(USC) Pain Center to study the genetics of chronic pain. The T.R.O.J.A.N. Study...
Read More

March 16, 2017 – Proove Release: Key Opinion Leaders Present Precision Medicine Research from Proove at American Academy of Pain Medicine Meeting

by | February 12, 2018 | Press Releases | 0 Comments

Proove continues its leadership of precision pain medicine presenting over 100 studies at major medical meetings outlining breakthrough precision medicine research over the past 5 years IRVINE, Calif., March 16, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. is...
Read More

December 7, 2016 – Proove Release: Proove Launches First Precision Medicine Test for TMJ Disorder

by | February 12, 2018 | In the News | 0 Comments

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain IRVINE, CA--(Marketwired - Dec 7, 2016) - Proove Biosciences, Inc., the...
Read More

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...
Read More

February 9, 2016 – Proove Release: Proove Presents Data at Leading Scientific Meeting

by | February 12, 2018 | In the News | 0 Comments

(PRWEB) February 19, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, presented findings on the link between genetics and pain at the American Academy of Pain Management's (AAPM) 32nd Annual Meeting. As the only company...
Read More

Video’s

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Get Instant Access to Updates to The Truth about Proove Bio